Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76768274 | 7676827 | 4 | F | 201011 | 20130917 | 20101119 | 20130930 | EXP | NL-MEDIMMUNE-MEDI-0011804 | MEDIMMUNE | 4.00 | MON | F | Y | 2.90000 | KG | 20130930 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76768274 | 7676827 | 1 | PS | SYNAGIS | 1 | INTRAMUSCULAR | D | 86870TF | 103770 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 76768274 | 7676827 | 1 | Antiviral prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 76768274 | 7676827 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 76768274 | 7676827 | Apnoea | |
| 76768274 | 7676827 | Asthenia | |
| 76768274 | 7676827 | Cyanosis | |
| 76768274 | 7676827 | Dyspnoea | |
| 76768274 | 7676827 | Electroencephalogram abnormal | |
| 76768274 | 7676827 | Fluid intake reduced | |
| 76768274 | 7676827 | Nervous system disorder | |
| 76768274 | 7676827 | Protein total increased | |
| 76768274 | 7676827 | Respiratory syncytial virus infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 76768274 | 7676827 | 1 | 2010 | 20101105 | 0 |